Azithromycin Tablets USP 500 mg
from: Zydus Life Science Limited
targets for comparison: zithromax tablets
The FDA recently granted final approval of azithromycin tablets USP 500 mg for the treatment of ear, lung, sinus, skin, throat and genital infections, as well as a variety of bacterial infections such as pneumonia, sexually transmitted infections and bronchitis. I was. The most common adverse events associated with azithromycin include diarrhea, nausea, vomiting, headache, and abdominal pain. Serious adverse events may include severe abdominal pain, watery or bloody diarrhea, irregular heartbeat, shortness of breath, sudden dizziness and liver problems.
For more information: zyduslife.com
Minocycline Hydrochloride Extended Release Tablets USP 55 mg, 65 mg, and 115 mg
from: Zydus Life Science Limited
targets for comparison: simino capsules
The FDA has finally approved minocycline hydrochloride extended release tablets 55 mg, 65 mg, and 115 mg for the treatment of moderate to severe acne in patients 12 years of age and older. Minocycline is a tetracycline antibiotic that stops the growth of bacteria that may make acne worse. Minocycline hydrochloride extended-release tablets are not effective against viral infections such as influenza. The most common adverse events associated with minocycline hydrochloride extended-release tablets include nausea, vomiting, diarrhea, lightheadedness, dizziness, and a spinning sensation.
For more information: zyduslife.com
Carboprost Tromethamine Injection USP 250 mcg/mL, Single Dose Vial
from: Aurobindo Pharma
targets for comparison: Hemabate sterile solution, 250 mcg/mL
Eugea Pharma Specialtys, a subsidiary of Aurobindo Pharma, received FDA approval to manufacture and market carboprost tromethamine injection USP 250 mcg/mL in single dose vials. The injection is a generic version of Pfizer’s sterile hemabate solution, 250 μg/mL, and is indicated for abortion during pregnancy (13-20 weeks). Also indicated for bleeding caused by uterine atony. The most common side effects include vomiting, diarrhea, nausea, temperature rise above 2°F, and flushing, but reactions are generally transient and reversible after treatment.
For more information: Aurobindo.com
Tadalafil Tablets USP 20 mg
from: Zydus Life Science Limited
targets for comparison: Adcirca
The FDA has approved tadalafil tablets USP 20 mg to treat the symptoms of pulmonary arterial hypertension. Tadalafil tablets are effective because they relax arteries, increase systemic blood flow, and improve exercise capacity, which may reduce clinical deterioration of symptoms. To improve hypertension, patients are recommended to take no more than 2 doses of 20 mg tadalafil once daily. The drug is generally well tolerated and the most common side effects are headache, muscle pain, nasal congestion, skin flushing, respiratory infections, upset stomach and muscle pain.
For more information: zyduslife.com